COMMUNIQUÉS West-GlobeNewswire

-
BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis
08/07/2025 -
Greenspace Leads Scientific Revival of Ayurveda With New Quantum-Based Approach
08/07/2025 -
Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors
08/07/2025 -
Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing
08/07/2025 -
PathAI Launches Precision Pathology Network to Advance AI-Powered Pathology
08/07/2025 -
Amarna Therapeutics and NorthX Biologics Finalize Agreement to Advance Nimvec™ AM510 Gene Therapy Toward Clinical Trials for Type 1 Diabetes
08/07/2025 -
Courtney Caputo Named Chair of the National Board of Directors at the Epilepsy Foundation of America
08/07/2025 -
Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM)
08/07/2025 -
Medicines for Poland lance un avertissement : sans usines pharmaceutiques, aucune guerre ne pourra être gagnée en Europe
08/07/2025 -
Comphya Closes Oversubscribed CHF 7.5 Million Series A Round to Advance U.S. and Australian Clinical Programs Following Strong Pilot Data
08/07/2025 -
WeightWatchers Completes Financial Reorganization, Strengthens Leadership, and Expands Program Innovation to Support Women Through Menopause
08/07/2025 -
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
08/07/2025 -
Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
08/07/2025 -
Novartis receives approval for first malaria medicine for newborn babies and young infants
08/07/2025 -
AB Science annonce le succès d'un placement privé de 1,925 millions d'euros
08/07/2025 -
AB Science announces the successful completion of a EUR 1.925 million private placement
08/07/2025 -
UAE Approves BioAro’s Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health
08/07/2025 -
Les Émirats arabes unis approuvent le complément Longevity+ de BioAro, ouvrant la voie à un fort potentiel sur le marché mondial de la santé préventive
08/07/2025 -
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
08/07/2025
Pages